Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests 81€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests 184€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  2. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  3. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  4. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  5. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  6. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  7. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed
  8. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  9. Zhang X, et al. 2022. Cell Rep. 40:111363. PubMed
  10. Witkowski MT, et al. 2022. Nat Immunol. 23:1424. PubMed
  11. Gazinska P, et al. 2022. Clin Cancer Res. 28:4494. PubMed
  12. Li S, et al. 2022. Nature. 610:373. PubMed
  13. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  14. Ors A, et al. 2022. Nucleic Acids Res. 50:11492. PubMed
  15. Ainsua-Enrich E, et al. 2022. iScience. 25:105455. PubMed
  16. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  17. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  18. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  19. Imanishi M, et al. 2022. Front Cardiovasc Med. 9:988713. PubMed
  20. Ye D, et al. 2023. Cell Mol Neurobiol. 43:2337. PubMed
  21. Lai ZZ, et al. 2023. Front Immunol. 14:992765. PubMed
  22. Long D, et al. 2023. Eur J Immunol. 53:e2250109. PubMed
  23. Lareau CA, et al. 2023. Nat Protoc. 18:1416. PubMed
  24. Jun SH, et al. 2023. Nat Commun. 14:982. PubMed
  25. Ryan FJ, et al. 2023. Cell Rep Med. 4:100971. PubMed
  26. Lakkis J, et al. 2022. Nat Mach Intell. 4:940. PubMed
  27. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  28. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  29. Ishikawa M, et al. 2023. Front Immunol. 14:998233. PubMed
  30. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  31. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  32. Yao L, et al. 2022. Cancer Res Commun. 2:1255. PubMed
  33. Vasaikar SV, et al. 2023. Nat Commun. 14:1684. PubMed
  34. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  35. Gao F, et al. 2023. Immunity. 56:864. PubMed
  36. Pinto C, et al. 2023. iScience. 26:106381. PubMed
  37. Im KW, et al. 2023. NPJ Breast Cancer. 9:22. PubMed
  38. Wu T, et al. 2023. Nat Methods. 20:723. PubMed
  39. Luo Y, et al. 2023. Cell Discov. 9:40. PubMed
  40. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  41. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  42. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  43. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  44. Thomas KA, et al. 2023. Transfusion. :S146. PubMed
  45. Boucher LE, et al. 2023. MAbs. 15:2195517. PubMed
  46. Lafôrets F, et al. 2023. iScience. 26:106514. PubMed
  47. Chen DY, et al. 2023. iScience. 26:106634. PubMed
  48. Solier S, et al. 2023. Nature. 617:386. PubMed
  49. Bera BS, et al. 2023. Epigenetics Chromatin. 16:14. PubMed
  50. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  51. Luoma S, et al. 2023. Cancers (Basel). 15:. PubMed
  52. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  53. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  54. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  55. Allard-Chamard H, et al. 2023. Cell Rep. 42:112630. PubMed
  56. Potts M, et al. 2023. Cell Rep. 42:112613. PubMed
  57. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  58. Du J, et al. 2023. Nat Commun. 14:3675. PubMed
  59. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  60. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  61. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  62. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  63. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  64. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  65. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  66. Bahri R, et al. 2020. Methods Mol Biol. 2163:227. PubMed
  67. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  68. McIlwain DR, et al. 2021. Cell Host Microbe. 29:1828. PubMed
  69. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  70. Chang M, et al. 2022. Biotechnol Bioeng. 119:1820. PubMed
  71. Ioannidis LJ, et al. 2022. STAR Protoc. 3:101269. PubMed
  72. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  73. Mair F, et al. 2022. Nature. 605:728. PubMed
  74. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  75. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  76. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  77. Campisi L, et al. 2022. Nature. 606:945. PubMed
  78. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  79. Neely J, et al. 2022. Front Immunol. 13:902232. PubMed
  80. Feyaerts D, et al. 2022. Cell Rep Med. 3:100680. PubMed
  81. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  82. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  83. Calabrese DR, et al. 2022. JCI Insight. 7: . PubMed
  84. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  85. Messing M, et al. 2022. Front Immunol. 13:1010216. PubMed
  86. Wei H, et al. 2022. Front Immunol. 13:1060695. PubMed
  87. Wheeler MM, et al. 2022. Nat Commun. 13:7592. PubMed
  88. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  89. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  90. Kim JR, et al. 2022. Cancer Immunol Immunother. :. PubMed
  91. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  92. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  93. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  94. Chow A 2023. Immunity. 56(1):93-106.e6. PubMed
  95. Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed
  96. Sun W, et al. 2023. Nature. 614:309. PubMed
  97. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  98. Heinen N, et al. 2023. Front Immunol. 13:1062210. PubMed
  99. Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed
  100. De Bakshi D, et al. 2023. Life Sci Alliance. 6: . PubMed
  101. Liao J, et al. 2023. Nat Commun. 14:207. PubMed
  102. Li Z, et al. 2022. J Thorac Dis. 14:4815. PubMed
  103. Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed
  104. Wang CQ, et al. 2023. Cells. 12: . PubMed
  105. Mohamed H, et al. 2023. Biomedicines. 11: . PubMed
  106. Ty M, et al. 2023. Sci Transl Med. 15:eadd9012. PubMed
  107. Sadashivaiah V, et al. 2023. BMC Neurosci. 24:6. PubMed
  108. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  109. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  110. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  111. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  112. Nandi I, et al. 2023. J Clin Invest. :. PubMed
  113. Chen SH, et al. 2022. Neurosci Bull. 38:290. PubMed
  114. Miller CL, et al. 2022. Cell Chem Biol. 29:451. PubMed
  115. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  116. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  117. Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed
  118. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  119. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  120. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  121. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  122. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  123. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  124. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  125. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  126. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  127. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  128. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  129. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  130. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  131. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  132. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  133. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  134. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  135. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  136. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  137. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  138. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  139. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  140. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  141. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  142. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  143. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  144. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  145. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  146. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  147. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  148. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  149. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  150. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  151. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  152. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  153. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  154. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  155. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  156. Jairaman A, et al. 2022. Elife. 11:. PubMed
  157. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  158. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  159. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  160. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  161. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  162. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  163. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  164. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  165. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  166. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  167. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  168. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  169. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  170. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  171. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  172. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  173. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  174. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  175. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  176. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  177. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  178. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  179. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  180. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  181. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  182. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  183. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  184. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  185. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  186. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  187. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  188. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  189. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  190. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  191. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  192. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  193. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  194. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  195. Ogbe A, et al. 2022. JCI Insight. . PubMed
  196. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  197. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  198. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  199. Woodruff MC, et al. 2022. Nature. :. PubMed
  200. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  201. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  202. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  203. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  204. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  205. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  206. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  207. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  208. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  209. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  210. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  211. Kumar V, et al. 2022. Cells. 11:. PubMed
  212. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  213. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  214. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  215. Vijayakumar B, et al. 2022. Immunity. . PubMed
  216. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  217. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  218. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  219. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  220. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  221. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  222. Dogra P, et al. 2020. Cell. 749:180. PubMed
  223. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  224. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  225. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  226. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  227. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  228. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  229. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  230. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  231. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  232. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  233. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  234. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  235. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  236. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  237. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  238. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  239. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  240. Kreutmair S, et al. 2021. Immunity. . PubMed
  241. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  242. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  243. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  244. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  245. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  246. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  247. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  248. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  249. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  250. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  251. Romine KA, et al. 2021. Cancer Discov. . PubMed
  252. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  253. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  254. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  255. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  256. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  257. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  258. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  259. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  260. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  261. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  262. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  263. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  264. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  265. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  266. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  267. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  268. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  269. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  270. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  271. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  272. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  273. Thijssen R, et al. 2022. Blood. :. PubMed
  274. Good Z, et al. 2022. Nat Med. :. PubMed
  275. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  276. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  277. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  278. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  279. Shi J, et al. 2014. Blood. 123:4015. PubMed
  280. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  281. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  282. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  283. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  284. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  285. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  286. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  287. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  288. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  289. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  290. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  291. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  292. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  293. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  294. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  295. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  296. Woodruff M, et al. 2020. medRxiv. . PubMed
  297. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  298. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  299. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  300. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  301. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  302. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  303. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  304. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  305. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  306. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  307. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  308. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  309. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  310. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  311. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  312. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  313. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  314. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  315. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  316. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  317. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  318. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  319. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  320. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  321. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  322. Burns JC, et al. 2020. eLife. 9:00. PubMed
  323. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  324. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  325. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  326. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  327. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  328. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  329. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  330. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  331. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  332. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  333. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  334. Wang J, et al. 2022. iScience. 25:103971. PubMed
  335. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  336. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  337. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  338. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  339. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  340. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  341. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  342. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  343. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  344. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  345. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  346. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  347. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  348. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  349. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  350. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  351. Song M, et al. 2018. Nature. 562:423. PubMed
  352. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  353. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  354. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  355. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  356. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  357. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  358. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  359. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  360. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  361. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  362. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  363. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  364. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  365. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  366. Feng W, et al. 2020. J Vis Exp. . PubMed
  367. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  368. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  369. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  370. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  371. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  372. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  373. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  374. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  375. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  376. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  377. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  378. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  379. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  380. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  381. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  382. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  383. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  384. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  385. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  386. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  387. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  388. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  389. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  390. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  391. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  392. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  393. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  394. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  395. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  396. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  397. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  398. Georg P, et al. 2022. Cell. 185:493. PubMed
  399. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  400. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  401. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  402. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  403. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  404. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  405. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  406. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  407. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  408. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  409. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  410. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  411. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  412. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  413. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  414. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  415. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  416. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  417. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  418. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  419. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  420. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  421. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  422. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  423. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  424. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  425. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  426. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  427. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  428. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  429. Lederer K, et al. 2022. Cell. . PubMed
  430. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  431. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  432. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  433. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  434. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  435. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  436. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  437. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  438. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  439. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  440. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  441. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  442. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  443. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  444. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  445. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  446. Adamo S, et al. 2022. Nature. 602:148. PubMed
  447. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  448. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  449. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  450. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  451. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  452. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  453. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  454. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  455. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  456. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  457. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  458. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  459. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  460. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  461. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  462. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  463. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  464. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  465. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  466. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  467. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  468. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  469. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  470. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  471. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  472. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  473. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  474. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  475. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  476. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  477. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  478. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  479. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  480. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  481. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  482. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  483. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  484. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  485. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  486. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  487. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  488. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  489. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  490. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  491. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  492. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  493. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  494. Chen C, et al. 2022. iScience. 25:103645. PubMed
  495. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  496. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  497. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  498. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  499. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  500. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  501. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  502. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  503. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  504. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  505. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  506. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  507. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  508. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  509. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  510. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  511. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  512. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  513. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  514. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  515. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  516. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  517. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  518. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  519. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  520. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  521. Wang EY, et al. 2021. Nature. 595:283. PubMed
  522. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  523. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  524. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  525. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  526. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  527. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  528. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  529. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account